Gastroenterology (all articles)
Consensus Recommendations: Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults.
15 Jun, 2022 | 10:58h | UTC
RCT: Discontinuation of Infliximab therapy in patients with Crohn’s disease.
15 Jun, 2022 | 10:54h | UTCDiscontinuation of Infliximab Therapy in Patients with Crohn’s Disease – NEJM Evidence
RCT: Vonoprazan triple and dual therapy for Helicobacter pylori infection.
15 Jun, 2022 | 10:41h | UTCVonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the US and Europe: Randomized Clinical Trial – Gastroenterology (link to abstract – $ for full-text)
Encephalopathy in cirrhosis: prevention and management.
15 Jun, 2022 | 10:39h | UTC
Review: Portal vein thrombosis in cirrhosis.
15 Jun, 2022 | 10:38h | UTCPortal Vein Thrombosis in Cirrhosis – Journal of Clinical and Experimental Hepatology
Review: Value of liver function tests in cirrhosis.
15 Jun, 2022 | 10:35h | UTCValue of Liver Function Tests in Cirrhosis – Journal of Clinical and Experimental Hepatology
Guideline: Functional bowel disorders with diarrhea.
14 Jun, 2022 | 11:20h | UTC
Position Paper: Diagnostic therapeutic care pathway for pediatric food allergies and intolerances.
14 Jun, 2022 | 11:05h | UTC
ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility.
14 Jun, 2022 | 10:59h | UTCCommentary: New guidelines for pancreatic cancer screening – Beth Israel Deaconess Medical Center
Commentary on Twitter
Sawhney et al share "ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations." https://t.co/P6OtmhXr2D pic.twitter.com/vDHWfKCAiN
— GIE (@GIE_Journal) May 26, 2022
Podcast: Gallbladder disease pearls.
14 Jun, 2022 | 10:46h | UTC#340 Gallbladder Disease – The Curbsiders
Case Series | Outbreak of hepatitis in children: clinical course of children with acute liver failure admitted to the intensive care unit.
13 Jun, 2022 | 10:46h | UTCOutbreak of hepatitis in children: clinical course of children with acute liver failure admitted to the intensive care unit – Intensive Care Medicine (if the link is paywalled, try this one)
Related: Investigating acute hepatitis of unknown origin in children (several resources on the subject)
Commentary on Twitter
Outbreak of non-A-E hepatitis in children, 🇬🇧 data. Good outcomes if ALF by dedicated liver #ICU with early referral to Tx centres, recognizing neuro-deterioration, high-volume #ECLS, close neuromonitoring/protection & support by hepatology/Tx physicians
📎https://t.co/GYAMaZbVGD pic.twitter.com/GA58vJWQIz— Intensive Care Medicine (@yourICM) June 10, 2022
RCT: Ustekinumab vs. adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn’s disease.
13 Jun, 2022 | 07:56h | UTCUstekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn’s disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
New @TheLancet – Sands et al – Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease (SEAVUE trial)https://t.co/Ov9ahRTQuC#IBD #GITwitter #Crohnsdisease pic.twitter.com/5f3vI6rRKd
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) June 10, 2022
Causes of liver cancer are changing around the world: some up, some down.
13 Jun, 2022 | 07:54h | UTCNews Release: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health
Original Study: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link to abstract – $ for full-text)
Systematic Review: N-Acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults.
9 Jun, 2022 | 10:27h | UTC
Consensus statements on the transition of adolescents and young adults with inflammatory bowel disease from pediatric to adult care.
8 Jun, 2022 | 11:03h | UTC
Systematic Review: Guaiac‐based fecal occult blood tests versus fecal immunochemical tests for colorectal cancer screening in average‐risk individuals.
8 Jun, 2022 | 10:59h | UTC
Commentary on Twitter
💩 Which faecal blood test is more accurate in detecting #bowelcancer and large polyps in population screening? https://t.co/U2mLfk7ARo This systematic review looks at the evidence from 63 studies including almost 4 million individuals. @CochranePH @CCGlobalAgeing @CochraneCRC pic.twitter.com/xQeeADgHql
— The Cochrane Library (@CochraneLibrary) June 7, 2022
Chronic anal pain: A review of causes, diagnosis, and treatment.
7 Jun, 2022 | 11:02h | UTC
Consensus Statement: Diagnostic action against hypertransaminasemia in pediatrics.
6 Jun, 2022 | 11:23h | UTC
RCT: Computer-aided device improves adenoma detection in colonoscopy for screening and surveillance colonoscopy.
6 Jun, 2022 | 11:03h | UTCCommentary: Colonoscopy With a Computer-Aided Device Boosted Adenoma Detection — Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure – MedPage Today (free registration required)
Review: Pathogenesis of alcohol-associated liver disease.
6 Jun, 2022 | 10:50h | UTCPathogenesis of Alcohol-Associated Liver Disease – Journal of Clinical and Experimental Hepatology
Guidelines for management of Clostridioides (Clostridium) difficile infection.
3 Jun, 2022 | 11:28h | UTC
Consensus on the diagnosis and treatment of cow’s milk protein allergy.
2 Jun, 2022 | 10:56h | UTC
Retrospective Cohort Study: Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer.
1 Jun, 2022 | 11:17h | UTC
Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: A meta-analysis beyond 10 years of follow-up.
31 May, 2022 | 11:47h | UTC
Commentary from the author on Twitter (thread – click for more)
https://twitter.com/alex_ford12399/status/1527601814765551616
Investigating acute hepatitis of unknown origin in children.
30 May, 2022 | 11:39h | UTCInvestigating Acute Hepatitis of Unknown Origin in Children – American Society for Microbiology
Related:
What’s sending kids to hospitals with hepatitis—coronavirus, adenovirus, or both? – Science
Puzzling pediatric hepatitis cases echo an earlier mysterious illness – STAT
Why COVID is a key suspect in severe hepatitis cases in kids worldwide – CBC
Hepatitis outbreak in children: What do we know so far? – Imperial College London
Explaining the unexplained hepatitis in children – The Lancet Infectious Diseases
Unexplained hepatitis cases in kids rise to 348 in 20 nations – CIDRAP
Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization
WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT
Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch
U.S., U.K. investigating unusual cases of hepatitis in young children – STAT
Mysterious liver illness seen in kids in US, Europe – Associated Press
Commentary on Twitter
Unexplained, severe acute hepatitis has been increasingly reported in children. Adenovirus has been detected in some (but not all) cases & is being investigated as 1 of many potential causes. @andreaprinzi discusses the ongoing epidemiologic investigation: https://t.co/P6EPdT8sOA
— ASM (@ASMicrobiology) May 27, 2022